Name | N-{4-[5-(3-Cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl]-2,3-di hydro-1H-inden-1-yl}-β-alanine hydrochloride (1:1) |
---|
Description | RP-001 is a picomolar short-acting S1P1 (EDG1) selective agonist, with an EC50 of 9 pM. RP-00 induces internalization and polyubiquitination of S1P1. RP-001 has little activity on S1P2-S1P4 and only moderate affinity for S1P5[1]. |
---|---|
Related Catalog | |
In Vitro | RP-001 elicits dose-dependent lymphopenia of CD4+ T cells. RP-001 induces acute lymphopenia with rapid recovery to untreated levels[1]. |
In Vivo | RP-001 causes dose-dependent rapid lymphopenia with an EC50 of 0.03 mg/kg[1]. |
References |
Molecular Formula | C24H24N4O4 |
---|---|
Molecular Weight | 468.93300 |
Exact Mass | 468.15600 |
PSA | 121.27000 |
LogP | 5.30698 |